52022XC1130(03)

English (current language)
Language
My EUR-Lex
- My EUR-Lex
- Sign in
- Register
- My recent searches (0)

This document is an excerpt from the EUR-Lex website

Search tips

Need more search options? Use the Advanced search

Document 52022XC1130(03)

Sintesi delle decisioni dell'Unione europea relative alle autorizzazioni all'immissione in commercio di medicinali dal 1° ottobre 2022 al 31 ottobre 2022 (pubblicate a norma dell'articolo 13 o dell'articolo 38 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio o Articolo 5 del regolamento (UE) 2019/6 del Parlamento europeo e del Consiglio)

PUB/2022/1458

OJ C 457, 30.11.2022, p. 1–8 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Languages, formats and link to OJ

HTML

PDF

Official Journal

To see if this document has been published in an e-OJ with legal value, click on the icon above (For OJs published before 1st July 2013, only the paper version has legal value).

Multilingual display

Text

30.11.2022

Gazzetta ufficiale dell’Unione europea

C 457/1

Sintesi delle decisioni dell'Unione europea relative alle autorizzazioni all'immissione in commercio di medicinali dal 1o ottobre 2022 al 31 ottobre 2022

(pubblicate a norma dell'articolo 13 o dell'articolo 38 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio (1) o Articolo 5 del regolamento (UE) 2019/6 del Parlamento europeo e del Consiglio (2))

(2022/C 457/01)

— Rilascio di un'autorizzazione all'immissione in commercio (articolo 13 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio): Accettate

Data della decisione

Denominazione del medicinale

DCI (denominazione comune internazionale)

Titolare dell'autorizzazione all'immissione in commercio

Numero d'iscrizione nel registro comunitario

Forma farmaceutica

Codice ATC (anatomico, terapeutico e chimico)

Data di notifica

3.10.2022

Spikevax

elasomeran

MODERNA BIOTECH SPAIN, S.L.

Calle del Principe de Vergara 132 Plt 12, 28002 Madrid, España

EU/1/20/1507

Dispersione per preparazione iniettabile

J07BX03

5.10.2022

10.10.2022

Comirnaty

tozinameran, vaccino a mRNA anti-COVID-19 (modificato a livello dei nucleosidi)

BioNTech Manufacturing GmbH

An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

Concentrato per dispersione iniettabile

Dispersione per preparazione iniettabile

J07BX03

10.10.2022

31.10.2022

Beyfortus

nirsevimab

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/22/1689

Soluzione iniettabile

J06BD08

3.11.2022

31.10.2022

Vaxzevria

Vaccino anti-COVID-19 (ChAdOx1-S [ricombinante])

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/21/1529

Sospensione iniettabile

J07BX03

31.10.2022

— Modifica di un'autorizzazione all'immissione in commercio (articolo 13 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio): Accettate

Data della decisione

Denominazione del medicinale

Titolare dell'autorizzazione all'immissione in commercio

Numero d'iscrizione nel registro comunitario

Data di notifica

3.10.2022

Genvoya

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/15/1061

4.10.2022

3.10.2022

Nuvaxovid

Novavax CZ, a.s.

Bohumil 138, 281 63 Jevany, Česká republika

EU/1/21/1618

5.10.2022

7.10.2022

Byfavo

PAION Deutschland GmbH

Heussstraße 25, 52078 Aachen, Deutschland

EU/1/20/1505

13.10.2022

7.10.2022

Pirfenidone axunio

axunio Pharma GmbH

Van-der-Smissen-Straße 1, 22767 Hamburg, Deutschland

EU/1/22/1655

13.10.2022

7.10.2022

Sunosi

TMC Pharma (EU) Limited

7a Durands Court, 45 Parnell Street, Waterford, Co. Waterford, X91 P381, Ireland

EU/1/19/1408

10.10.2022

12.10.2022

Aripiprazole Sandoz

Sandoz GmbH

Biochemiestrasse 10, 6250 Kundl, Österreich

EU/1/15/1029

13.10.2022

14.10.2022

Adtralza

Leo Pharma A/S

Industriparken 55, 2750 Ballerup, Danmark

EU/1/21/1554

19.10.2022

14.10.2022

ALPROLIX

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, Sverige

EU/1/16/1098

18.10.2022

14.10.2022

Alunbrig

Takeda Pharma A/S

Delta Park 45, 2665 Vallensbaek Strand, Danmark

EU/1/18/1264

17.10.2022

14.10.2022

ARIKAYCE liposomal

Insmed Netherlands B.V.

Stadsplateau 7, 3521 AZ Utrecht, Nederland

EU/1/20/1469

6.11.2022

14.10.2022

Bexsero

GlaxoSmithKline Vaccines S.r.l.

Via Fiorentina, 1, 53100 Siena, Italia

EU/1/12/812

17.10.2022

14.10.2022

Cegfila

Mundipharma Corporation (Ireland) Limited

Millbank House, Arkle Road, Sandyford Industrial Estate, Dublin 18, Ireland

EU/1/19/1409

19.10.2022

14.10.2022

Cystagon

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/97/039

17.10.2022

14.10.2022

Drovelis

Gedeon Richter Plc.

Gyömrői út 19-21, 1103 Budapest, Magyarország

EU/1/21/1547

17.10.2022

14.10.2022

Dzuveo

Laboratoire Aguettant

1 Rue Alexander Fleming, 69007 Lyon, France

EU/1/18/1284

17.10.2022

14.10.2022

ELZONRIS

Stemline Therapeutics B.V.

Basisweg 10, 1043 AP, Amsterdam, Noord-Holland, Nederland

EU/1/20/1504

18.10.2022

14.10.2022

Empliciti

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/16/1088

17.10.2022

14.10.2022

Entacapone Orion

Orion Corporation

Orionintie 1, 02200 Espoo, Suomi

EU/1/11/708

17.10.2022

14.10.2022

Icandra

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/08/484

18.10.2022

14.10.2022

Imlygic

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/15/1064

17.10.2022

14.10.2022

Imnovid

Bristol Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

EU/1/13/850

17.10.2022

14.10.2022

KEYTRUDA

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/15/1024

17.10.2022

14.10.2022

Nepexto

Mylan IRE Healthcare Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/20/1436

17.10.2022

14.10.2022

Nevanac

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/07/433

17.10.2022

14.10.2022

Nilemdo

Daiichi Sankyo Europe GmbH

Zielstattstraße 48, 81379 München, Deutschland

EU/1/20/1425

18.11.2022

14.10.2022

Nustendi

Daiichi Sankyo Europe GmbH

Zielstattstraße 48, 81379 München, Deutschland

EU/1/20/1424

20.10.2022

14.10.2022

Omnitrope

Sandoz GmbH

Biochemiestrasse 10, 6250 Kundl, Österreich

EU/1/06/332

17.10.2022

14.10.2022

Ovitrelle

Merck Europe B.V.

Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

EU/1/00/165

17.10.2022

14.10.2022

Pergoveris

Merck Europe B.V.

Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

EU/1/07/396

17.10.2022

14.10.2022

Revlimid

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/07/391

17.10.2022

14.10.2022

Revolade

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/10/612

17.10.2022

14.10.2022

Skyrizi

AbbVie Deutschland GmbH & Co. KG

Knollstrasse, 67061 Ludwigshafen, Deutschland

EU/1/19/1361

17.10.2022

14.10.2022

Vectibix

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/07/423

17.10.2022

14.10.2022

Xolair

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/05/319

17.10.2022

14.10.2022

Yescarta

Kite Pharma EU B.V.

Tufsteen 1, 2132 NT Hoofddorp, Nederland

EU/1/18/1299

17.10.2022

14.10.2022

Zomarist

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/08/483

17.10.2022

20.10.2022

Anagrelide Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/17/1256

21.10.2022

20.10.2022

Comirnaty

BioNTech Manufacturing GmbH

An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

20.10.2022

Dynastat

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/02/209

21.10.2022

20.10.2022

Evra

Gedeon Richter Plc.

Gyömrői út 19-21, 1103 Budapest, Magyarország

EU/1/02/223

25.10.2022

20.10.2022

Orkambi

Vertex Pharmaceuticals (Ireland) Limited

Unit 49, Block F2, Northwood Court, Santry, Dublin 9, D09 T665, Ireland

EU/1/15/1059

21.10.2022

20.10.2022

Paxlovid

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/22/1625

21.10.2022

20.10.2022

Rapamune

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/01/171

21.10.2022

20.10.2022

Rezolsta

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/14/967

21.10.2022

20.10.2022

Spikevax

MODERNA BIOTECH SPAIN, S.L.

Calle del Principe de Vergara 132 Plt 12, 28002 Madrid, España

EU/1/20/1507

20.10.2022

Vaxzevria

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/21/1529

20.10.2022

Veklury

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/20/1459

20.10.2022

Xelevia

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/07/382

24.10.2022

21.10.2022

Eylea

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/12/797

24.10.2022

21.10.2022

Inflectra

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/13/854

24.10.2022

21.10.2022

Vaxneuvance

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/21/1591

24.10.2022

28.10.2022

Brukinsa

BeiGene Ireland Limited

10 Earlsfort Terrace, Dublin 2, D02 T380, Co. Dublin, Ireland

EU/1/21/1576

3.11.2022

28.10.2022

Comirnaty

BioNTech Manufacturing GmbH

An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

28.10.2022

Enhertu

Daiichi Sankyo Europe GmbH

Zielstattstraße 48, 81379 München, Deutschland

EU/1/20/1508

3.11.2022

28.10.2022

REKAMBYS

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1482

2.11.2022

28.10.2022

VPRIV

Takeda Pharmaceuticals International AG Ireland Branch

Block 3 Miesian Plaza, 50 — 58 Baggot Street Lower, Dublin 2, Ireland

EU/1/10/646

2.11.2022

28.10.2022

XALKORI

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/12/793

2.11.2022

31.10.2022

Adasuve

Ferrer Internacional S.A.

Gran Via Carlos III, 94 08028 Barcelona, España

EU/1/13/823

7.11.2022

31.10.2022

JCOVDEN

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1525

2.11.2022

31.10.2022

Ofev

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/14/979

3.11.2022

31.10.2022

Pregabalin Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/15/997

3.11.2022

31.10.2022

Rivastigmine HEXAL

Hexal AG

Industriestraße 25, 83607 Holzkirchen, Deutschland

EU/1/09/589

8.11.2022

31.10.2022

RXULTI

Otsuka Pharmaceutical Netherlands B.V.

Herikerbergweg 292, 1101 CT, Amsterdam, Nederland

EU/1/18/1294

7.11.2022

31.10.2022

Tafinlar

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/13/865

3.11.2022

31.10.2022

Zercepac

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/20/1456

3.11.2022

— Modifica di un'autorizzazione all'immissione in commercio (articolo 38 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio; Articolo 5 del regolamento (UE) 2019/6 del Parlamento europeo e del Consiglio): Accettate

Data della decisione

Denominazione del medicinale

Titolare dell'autorizzazione all'immissione in commercio

Numero d'iscrizione nel registro comunitario

Data di notifica

7.10.2022

Improvac

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/09/095

10.10.2022

7.10.2022

Rabitec

Ceva Santé Animale

10 avenue de La Ballastière, 33500 Libourne, France

EU/2/17/219

10.10.2022

7.10.2022

Tulinovet

V.M.D.n.v.

Hoge Mauw 900, 2370 Arendonk, Belgïe

EU/2/20/257

14.10.2022

7.10.2022

Virbagen Omega

VIRBAC

1ère Avenue — 2065m — L.I.D., 06516 CARROS, France

EU/2/01/030

10.10.2022

17.10.2022

Bonqat

Orion Corporation

Orionintie 1, 02200 Espoo, Suomi

EU/2/21/273

19.10.2022

17.10.2022

Bovilis Blue-8

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/17/218

18.10.2022

17.10.2022

Chanhold

Chanelle Pharmaceuticals Manufacturing Limited

Loughrea, Co. Galway, Ireland

EU/2/19/236

18.10.2022

17.10.2022

CLYNAV

Elanco GmbH

Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland

EU/2/16/197

18.10.2022

17.10.2022

Easotic

VIRBAC

1ère avenue 2065 m LID, 06516 Carros, France

EU/2/08/085

19.10.2022

17.10.2022

EVICTO

VIRBAC

1ère avenue 2065 m LID, 06516 Carros, France

EU/2/19/242

18.10.2022

17.10.2022

MHYOSPHERE PCV ID

Laboratorios Hipra, S.A.

Avda. La Selva, 135, 17170 Amer (Girona), España

EU/2/20/259

18.10.2022

17.10.2022

Nobivac LeuFel

VIRBAC

1ère avenue 2065 m LID, 06516 Carros, France

EU/2/17/217

18.10.2022

17.10.2022

Poulvac E. coli

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/12/140

18.10.2022

17.10.2022

Rabigen SAG2

VIRBAC S.A.

1ère Avenue — 2065 m — L.I.D., 06516 Carros CEDEX, France

EU/2/00/021

19.10.2022

25.10.2022

EVICTO

VIRBAC

1ère avenue 2065 m LID, 06516 Carros, France

EU/2/19/242

26.10.2022

25.10.2022

Exzolt

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/17/212

26.10.2022

25.10.2022

Solensia

Zoetis Belgium SA

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/20/269

26.10.2022

28.10.2022

Improvac

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/09/095

2.11.2022

28.10.2022

Improvac

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/09/095

2.11.2022

28.10.2022

Porcilis PCV M Hyo

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/14/175

1.11.2022

28.10.2022

PREVEXXION RN

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/20/254

2.11.2022

28.10.2022

PREVEXXION RN+HVT+IBD

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/20/255

2.11.2022

28.10.2022

Purevax RCPCh

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/04/050

2.11.2022

28.10.2022

Vaxxitek HVT + IBD

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/02/032

2.11.2022

Per consultare la relazione pubblica di valutazione sui medicinali in questione e le correlate decisioni contattare:

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

(1) GU L 136 del 30.4.04, pag. 1.

(2) GU L 4 del 7.1.2019, pag. 43.

Top